Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Amber Specialty Pharmacy

Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Named 2024 Specialty Pharmacy of The Year by the National Association of Specialty Pharmacy
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Announces Access to Galderma's New Medication for Prurigo Nodularis
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected to Dispense Rezdiffra™ to Treat Noncirrhotic Non-Alcoholic Steatohepatitis
From Amber Specialty Pharmacy
Via Business Wire
Jessica Ringena Named President of Amber Specialty Pharmacy
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Celebrates Its 25th Anniversary with the Launch of New Transplant Patient Recovery Program
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected to Dispense VOWST™ Capsules for the Prevention of Recurrence of C. Difficile Infection in Adults
From Amber Specialty Pharmacy
Via Business Wire
Craig Holtgrave Joins Amber Specialty Pharmacy as Senior Vice President of Business Innovation
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Named Partner of WeInfuse’s Specialty Pharmacy Connect Program
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected to Dispense TZIELD™ (teplizumab), a Monoclonal Antibody Treatment to Delay Onset of Stage 3 Type 1 Diabetes in Patients Ages 8 Years and Older with Stage 2 Type 1 Diabetes
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Added to Pfizer’s Limited Distribution Network for Oncology Portfolio
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Earns URAC Rare Disease Pharmacy Center of Excellence Designation
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Announces Expanded EVUSHELD™ Services
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Added to Eisai’s LENVIMA® Network
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions Selected to Dispense TEZSPIRE™ (tezepelumab) for the Treatment of Severe Asthma
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy’s Peggy Tomes Receives the 2021 Specialty Pharmacy Service Excellence Award from the National Association of Specialty Pharmacy
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected by Takeda to Dispense LIVTENCITY™ (maribavir) for the Treatment of Adults and Pediatric Patients with Post-Transplant CMV Infection/Disease that is Refractory to Treatment
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions Announce Additional Monoclonal Antibody Treatment Option for COVID-19
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Announces Promotions
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense TAVNEOS™ (avacopan), an Adjunctive Treatment for ANCA-Associated Vasculitis
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions to Expand Support of Lilly’s Monoclonal Antibody Treatment for COVID-19
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions Launch COVID-19 Response to Help Hospitals & Physicians Administer Regeneron Monoclonal Antibody Treatment
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Launches Mobile App to Improve Specialty Pharmacy Patient Experience
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy Selected by Kadmon to Dispense REZUROCK™ (belumosudil) Tablets for Chronic Graft-Versus-Host Disease Patients
From Amber Specialty Pharmacy
Via Business Wire
Amber Specialty Pharmacy to Dispense ADUHELM™ (aducanumab) for the Treatment of Alzheimer’s
From Amber Specialty Pharmacy
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.